Results for tag: "CD Antigen Cancer Therapy"

CD Antigen Cancer Therapy is a type of oncology drug used to treat cancer. It is a form of immunotherapy, which works by stimulating the body's own immune system to recognize and attack cancer cells. The therapy works by introducing a specific antigen, or protein, to the body that is recognized by the immune system as foreign. This triggers an immune response, which can help to destroy cancer cells. CD Antigen Cancer Therapy is used to treat a variety of cancers, including breast, lung, and colorectal cancer. It is also used to treat some types of leukemia and lymphoma. The CD Antigen Cancer Therapy market is a rapidly growing segment of the oncology drug market. It is expected to continue to grow as more research is conducted and new treatments are developed. Companies in the market include Merck, Bristol-Myers Squibb, AstraZeneca, and Novartis. Show Less Read more